Description
GLP3 Reta is an experimental peptide that targets GLP-1, GIP, and glucagon receptors and is currently being studied for its potential impact on blood glucose regulation and body weight. This substance is not approved for medical use .
FOR RESEARCH PURPOSES ONLY – IMPORTANT DISCLAIMER
This compound is intended for laboratory and in vitro research use only . It is not intended for human or animal consumption , clinical use, or diagnostic use.
By making a purchase, you confirm that you have read and accept this disclaimer.
